Indian and Japanese firms advise on Medreich pharma deal

June 30, 2014 Khaitan & Co, Anderson Mori & Tomotsune and Amarchand Mangaldas have taken leading roles in the deal for the puchase of Bangalore pharma company Medreich by Japanese company Meiji Seika Pharma for Rs 1720 crore ($290m).

Meiji Seika Pharma is advised by Khaitan & Co and Anderson Mori & Tomotsune, while Medreich iss advised by Amarchand Mangaldas.

Khaitan’s team includes corporate partner Bhavik Narsana, banking and finance partner Kumar Saurabh Singh, competition law partner Avaantika Kakkar, intellectual property partner Adheesh Nargolkar, real estate partner Abhishek Sharma and regulatory partner Sharad Vaid, while Anderson Mori’s team is led by Yuichiro Nukada and Ryo Okochi.

From Amarchand, the deal is handled by corporate partner Ashish Jejurkar and tax partner SR Patnaik.

comments powered by Disqus